Select Page

Home » Services » Bellafill

Bellafill

bellafill

Bellafill® (formally Artefill®) is an injectable filler that provides natural looking correction while restoring facial volume. It is also effective in the treatment of acne scars.

Bellafill® is different from temporary injectable fillers. The unique microspheres in Bellafill® are not absorbed by the body and provide the support your skin needs for natural looking results. It also has been found to last longer* than other fillers.

If you have used temporary fillers in the past, then you know that they are eventually absorbed by your body and require frequent repeat injections to maintain the results you’ve come to love.

Dr. Pierone is the leading injector of Bellafill® in the United States and is a nationally recognized trainer and researcher. He has performed over 20,000 procedures with dermal fillers.

Before and After

Women

How Betlama Covers the Key Rules of Canadian Sports Betting

Sports betting in Canada has undergone a remarkable transformation over the past several years, evolving from a tightly restricted activity into a regulated, consumer-focused industry. For decades, Canadians were limited to parlay-style wagers through provincial lottery corporations, with single-event betting remaining legally off-limits. The passage of Bill C-218 in August 2021 changed everything, allowing provinces to regulate and offer single-event sports wagering for the first time. This shift created both opportunities and responsibilities — for operators, regulators, and bettors alike. Understanding the rules that govern this landscape is essential for anyone participating in it, and platforms that clearly communicate these regulations play a vital role in shaping an informed betting public.

The Regulatory Framework Behind Canadian Sports Betting

Canada's approach to sports betting regulation is notably decentralized. Unlike the United States, where federal legislation like the Professional and Amateur Sports Protection Act (PASPA) once held sweeping authority, Canada delegates gambling regulation primarily to its provinces and territories. Each province operates under its own gaming authority, and the legal frameworks can differ significantly from one region to another. Ontario, for instance, launched its open, competitive iGaming market in April 2022 through the Alcohol and Gaming Commission of Ontario (AGCO), becoming the first province to allow private operators to offer sports betting legally alongside the provincial operator OLG. British Columbia, Alberta, and Manitoba continue to operate through their respective provincial Crown corporations, while Quebec maintains its own distinct regulatory posture through Loto-Québec.

This patchwork of regulations means that a bettor in Toronto operates under different rules than one in Vancouver or Calgary. Age verification requirements, responsible gambling mandates, advertising restrictions, and technical standards for platforms all vary by jurisdiction. For example, Ontario's iGaming framework requires all registered operators to adhere to strict standards around data privacy, anti-money laundering protocols, and the display of responsible gambling tools such as deposit limits, self-exclusion options, and session time reminders. These are not optional features — they are embedded requirements that operators must implement to maintain their licenses.

The Criminal Code of Canada also plays a foundational role. Before Bill C-218, Section 207 of the Criminal Code restricted betting to "three or more events," effectively banning single-game wagering. The amendment to this section opened the door to provincial regulation of single-event betting, but the Criminal Code still sets outer boundaries. Betting on amateur sports involving minors, for instance, remains prohibited at the federal level regardless of provincial rules. Understanding this layered legal architecture is critical for any serious participant in Canadian sports betting.

How Betlama Approaches Rule Transparency and Bettor Education

One of the persistent challenges in the Canadian sports betting market is ensuring that bettors understand not only how to place wagers but also what rules govern those wagers and what protections exist for them. Many platforms prioritize the mechanics of betting — odds formats, bet types, live wagering — without sufficiently explaining the regulatory context in which those activities occur. Betlama takes a notably different approach by integrating informational content about the rules and legal standards that shape the Canadian betting environment directly into its platform experience.

This commitment to transparency is evident in how Betlama structures its content around provincial distinctions. Rather than presenting a one-size-fits-all overview of Canadian betting, the platform acknowledges that a user in Ontario is subject to AGCO oversight, while a user in another province may be interacting with a Crown corporation model. This nuance matters enormously for bettors who want to understand their rights, the complaint resolution processes available to them, and the specific responsible gambling resources they can access. Platforms that gloss over these distinctions do a disservice to users who may not realize that their protections differ based on where they live.

For those looking to deepen their understanding of how Canadian sports betting regulations work in practice, https://betlama.com/ provides a structured and accessible breakdown of the key rules, covering everything from how odds are calculated and displayed to how disputes between bettors and operators are typically resolved under provincial frameworks. This kind of educational infrastructure is increasingly recognized as a best practice in regulated markets, where informed bettors are better equipped to make responsible decisions and less likely to fall victim to predatory or non-compliant practices.

Betlama also addresses the often-overlooked area of bonus and promotional rules. In Ontario, the AGCO has established specific guidelines around how bonuses can be advertised and what terms must be disclosed upfront. Wagering requirements, expiry dates, and game restrictions must be clearly communicated, and operators cannot use misleading language to inflate the perceived value of an offer. By explaining these standards in plain language, Betlama helps bettors evaluate promotional offers critically rather than accepting them at face value — a skill that has real financial implications over time.

Key Betting Rules Every Canadian Sports Bettor Should Understand

Beyond the regulatory framework, there are specific operational rules that govern how bets are placed, accepted, and settled — and these rules can have significant consequences for bettors who are unaware of them. One of the most important is the concept of "void bets." In Canadian sports betting, a wager may be declared void if an event is cancelled, postponed beyond a specified window, or if a key condition of the bet — such as a specific player participating — is not met. Different operators apply these rules differently, and understanding the void bet policy before placing a wager is essential.

Another critical area involves the rules around live or in-play betting. Canada's regulated platforms are permitted to offer in-play wagering, but the rules governing these bets are often more complex than pre-match wagers. Odds can change rapidly, bets may be suspended during key moments in a game, and the settlement process for in-play bets can differ from traditional wagers. Some operators reserve the right to void in-play bets if there is evidence of a technical error in the odds feed, a provision that is typically buried in the terms and conditions but can have meaningful consequences.

Parlay betting, which remains enormously popular in Canada given its historical roots as the dominant form of legal sports wagering, also carries specific rules that bettors should understand. A parlay combines multiple selections into a single bet, with all selections needing to win for the bettor to collect. However, if one leg of a parlay is voided — due to a postponed game, for example — the rules vary by operator. Some platforms reduce the parlay by one leg and recalculate the odds; others may void the entire ticket. Betlama's educational content specifically addresses these scenarios, helping bettors understand what to expect before they commit their stake.

Responsible gambling rules are another dimension that deserves serious attention. All provincially regulated operators in Canada are required to offer self-exclusion programs, and in Ontario, the AGCO's iGaming Ontario framework integrates with the province's broader self-exclusion registry. This means that a person who self-excludes from one registered operator is effectively excluded from all of them within the Ontario framework — a significant consumer protection measure. Deposit limits, cooling-off periods, and reality checks are also mandated tools that operators must make available, and bettors have the right to use them without penalty or restriction.

The Evolving Landscape and What Bettors Can Expect Going Forward

The Canadian sports betting market is still relatively young in its current regulated form, and the rules governing it continue to evolve. Ontario's model has attracted significant attention from other provinces considering whether to open their markets to private competition. The success of Ontario's framework — which generated substantial tax revenue and channeled a meaningful portion of previously offshore betting activity into the regulated market — has created a template that other provinces are studying carefully. Alberta has signaled interest in developing a more competitive market structure, and the federal government has indicated ongoing review of the Criminal Code provisions that still shape the outer limits of what is permissible.

Advertising standards are also under increasing scrutiny. The volume of sports betting advertising in Canada, particularly around live sports broadcasts, prompted a significant industry response in 2023 when major broadcasters and operators agreed to voluntary restrictions on certain types of advertising, including the use of athlete endorsements in direct betting promotions. Regulatory bodies are expected to formalize some of these restrictions, bringing Canadian standards closer in line with stricter regimes seen in the United Kingdom, where the Gambling Commission has implemented some of the most comprehensive advertising rules in the world.

Technology is also reshaping the regulatory conversation. The rise of geolocation technology, artificial intelligence-based responsible gambling tools, and blockchain-based transparency mechanisms are all influencing how regulators think about oversight. Ontario's AGCO has already indicated that it expects operators to leverage available technology to enhance compliance rather than using technical limitations as an excuse for regulatory gaps. Betlama's ongoing coverage of these developments reflects the broader understanding that the rules of Canadian sports betting are not static — they are a living framework that responds to market conditions, consumer behavior, and policy priorities.

For bettors, staying informed about these changes is not merely academic. Rule changes can affect the value of certain bet types, the availability of specific markets, or the terms under which promotions are offered. Platforms that communicate these changes clearly and promptly provide a genuine service to their users, building the kind of trust that is increasingly recognized as a competitive differentiator in a crowded market.

Conclusion

Canada's sports betting landscape is one of the most dynamic and consequential in the world right now, shaped by recent legislative change, provincial diversity, and rapidly evolving consumer expectations. The rules that govern this space — from the Criminal Code framework to provincial licensing standards to operator-level terms and conditions — form a complex but navigable system for those who take the time to understand them. Betlama's focus on rule transparency and bettor education represents a meaningful contribution to this ecosystem, helping Canadians engage with sports betting in an informed, responsible, and legally aware manner. As the market continues to mature, this kind of educational commitment will only grow in importance.

Men

How Does it Work?

Bellafill® is an FDA-approved, natural looking dermal filler comprised of collagen and PMMA microspheres.

More

bellafillUnlike other types of fillers, Bellafill® replaces collagen in the face and restructures the skin to support natural looking results.

The effects of Bellafill® come from the collagen, which is absorbed by the body over time. The PMMA microspheres provide enduring wrinkle correction by creating a support matrix for the body’s natural collagen. The unique microspheres in Bellafill® are not absorbed by the body and create a support matrix for wrinkle correction by working together with your body’s own collagen.

Upon injection, the collagen in Bellafill® visibly reduces the wrinkles right away and the microspheres provide support for your skin. Your body’s own collagen works together with the microspheres to provide natural feeling wrinkle reduction.

What to Expect

Bellafill® is injected with the assistance of a microcannula, the latest revolution in injection techniques!

Here's what to expect:

Using a technique known as skin sculpting, we will literally slide the Microcannula under your skin so that the filler can be applied with practically no pain or bruising for the patient.

There is typically a low incidence of side effects with Bellafill®, but expect redness after treatment, mild swelling and mild discomfort 24 hours after treatment.

Important Safety Information
Bellafill® is indicated for the correction of nasolabial folds and moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years.

Reference: www.bellafill.com

FAQs

What distinguishes it from other fillers on the market?
Bellafill is the only FDA approved permanent filler. It is actually a hybrid product – 80% bovine collagen and 20% PMMA. The PMMA is the permanent component.

One of the misconceptions about Bellafill is that it is a one and done procedure. As the bovine collagen is reabsorbed, the PMMA microspheres are surrounded by macrophages and multi-nucleated giant cells along with bands of naturally produced collagen. However this volume is less than the bovine collagen that was injected, so there is an overall reduction in volume as compared with the immediate result. Subsequent injection sessions require fewer Bellafill syringes to achieve correction since they build upon the previous permanent PMMA filler base. Practitioners and patients need to understand that with Bellafill they are using a truly permanent facial filler but that a series of treatment sessions will be needed to achieve optimal results.

Please comment on Bellafill's safety profile.
The most common question that clinicians and patients have about Bellafill has to do with its safety profile. The obvious concern is that with a permanent filler, potential complications may be permanent as well. I think that there are three potential complications that need to be considered for anyone considering treatment with Bellafill.

Skin testing for bovine collagen allergy is recommended before treatment with Bellafill. Personally, I don’t perform the bovine collagen skin test, because bovine collagen allergy is quite unusual, and if it occurs, it is easily managed. I include the omission of the skin test in my written informed consent for patients. Also, a negative skin test is not entirely predictive, and a bovine collagen hypersensitivity reaction may still occur. I have seen this happen in patients with a negative skin test. But again, if it does occur, this problem is easily managed with a short course of corticosteroids and antihistamines. It is also completely reversible.

The second safety issue is the possibility of producing a nodule or lump. This complication tends to be related to sub-optimal injection technique. The product itself is very smooth and when properly injected nodules should be quite rare. That said, Bellafill should only be injected by highly experienced practitioners who have mastered facial injection techniques. If lumps or nodules do develop, they may be effectively managed with serial injections of corticosteroids with or without injection of 5 fluorouracil. On rare occasions, surgical removal may become necessary.

Granulomas are the other potential complication related to facial fillers, including Bellafill. The company completed a five year safety study in over 1000 patients that showed a five year rate of granuloma of 1.7%. Granulomas typically present as single or multiple inflammatory nodules in the regions where Bellafill was injected. They are managed with serial injections of corticosteroids with or without injection of five fluorouracil. In some cases, hyaluronic acid-based fillers may be required to camouflage the granulomas as they are resolving. It should be noted that granulomas represent an overly robust immunologic reaction to the PMM A microspheres, and favorably respond to corticosteroid injections. Surgical removal is inappropriate, medical therapy is the proper course of action.

Who are good candidates for Bellafill?
The best candidates for Bellafill are experienced patients who have had good results with facial fillers in the past, and are looking for a permanent result. For many people, facial filler fatigue may set in. It takes a commitment to continually see a practitioner for repetitive injections of temporary facial fillers. There are also many people who are thin, very active, and have higher metabolic rates who seem to require more frequent injections with temporary facial fillers. These fast metabolizer may also be good candidates for Bellafill.
Please describe patient satisfaction.
Patient satisfaction is typically quite high. If you look on the website Real Self, Bellafill approval rating is 90%. My practice experience mirrors this positive patient response. The great majority of patients are satisfied and appreciate the permanent results. I often see return patients who remain pleased with the series of Bellafill treatments that they received years before.
Is there anything you would like to add?
Although it is an off label indication, my use of Bellafill has evolved over the last five years. I now very often will use Bellafill as a deep structural filler directly on periosteum to mimic bone volume. This includes the malar eminence, the mandible, and chin. If you think about it, the truth is that this product may be used as a substitute for a surgical facial implant.

I am also several years into an FDA approved long-term safety and efficacy study of Bellafill for treatment of HIV related lipoatrophy. I have 30 subjects who have received over 30 syringes of Bellafill over a one year treatment and who then are followed for two additional years. The results have been overwhelmingly positive, and quite frankly, life-changing in this patient population.

I have surgeons and dermatologists who cite t permanent nature of Bellafill as the primary reason that they will not use this filler. For fair balance though, some of these practitioners would not hesitate to recommend a surgical procedure, which by their nature, may produce permanent problems as well.

Is it safe?
Bellafill® is indicated for the correction of nasolabial folds and moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years. Patients who have had a positive reaction to the Bellafill® Skin Test, have a history of severe allergies, have known bovine collagen allergies, are allergic to lidocaine, have bleeding disorders or are prone to thick scar formation and/or excessive scarring should not receive Bellafill®. The safety of Bellafill® for use during pregnancy, breastfeeding, or in patients under 21 has not been established. You may experience temporary swelling, redness, pain, bruising, lumps/bumps, itching, and discoloration at the treatment site. These side effects are usually transient and typically resolve within 1–7 days. You may experience lumps/bumps/papules that may occur more than one month after injection and that may persist. Less common side effects include rash and itching more than 48 hours after treatment, persistent swelling or redness, lumps/bumps, acne, and increased sensitivity at treatment sites. Infrequently, granulomas may occur and may be treated by Dr. Pierone. Based on the 5-year Post-Approval Study on nasolabial folds with 1,008 patients, long-term safety of Bellafill® for up to 5 years has been established.(2)
Will it work for me?
In a clinical trial, Bellafill® was shown to work equally well with all skin types, and in men and women. Patients who have had a positive reaction to the Bellafill® Skin Test, have a history of severe allergies, have known bovine collagen allergies, are allergic to lidocaine, have bleeding disorders or are prone to thick scar formation and/or excessive scarring should not receive Bellafill®.
When will I see results?
Bellafill® replaces lost volume in the skin below the wrinkle for correction that is noticeable and lasting.(2)
What's the downtime?
You can return to normal activities right away. As with any injectable dermal filler, you may experience temporary swelling, redness, pain, bruising, lumps/bumps, itching, and discoloration at the treatment site. These side effects are usually transient and typically resolve within 1-7 days.
How long does it last?
The PMMA microspheres provide a microscopic ‘matrix’ to support your body’s own natural collagen production and re-create the firm structure of younger-looking skin for lasting correction, proven effective through 5 years(2). This number is potentially much higher but has not been tested in long duration clinical trials.

www.bellafill.com/FAQ
References: 1. Gottfried Lemperle, et. al., ArteFill® Permanent Injectable for Soft Tissue Augmentation: I. Mechanism of Action and Injection Techniques., Aesthetic Plast Surg. 2010 Jun;34(3):264–72. 2. Bellafill® [Instructions for Use]. San Diego, CA: Suneva Medical, Inc.; 2015. 3. Jacob CI, Dover JS, Kaminer MS. Acne scarring: A classification system and review of treatment options. J Am Acad Dermatol; July 2001; 109-117. 4. Data on file. Suneva Medical, Inc. 5. Haneke et al. Polymethyl Methacrylate Microspheres in Collagen. Semin Cutan Med Surg 23:227-232,2004. 6. Cohen et al. Artecoll: A Long-Lasting Injectable Wrinkle Filler Material: Report of a Controlled, Randomized, Multicenter Clinical Trial of 251 Subjects. Plast. Reconstr. Surg. 114: 964,2004. 7. American Academy of Dermatology, http://www.aad.org/media-resources/stats-and-facts/conditions/acne#.Uc2hG_nvt8F. 8. Journal of Plastic, Reconstructive and Aesthetic Surgery, 2008, http://www.sciencedirect.com/science/article/pii/S1748681508003951. 9. Formula PR Independent Study, 2013. 10. Suneva Medical AAD Advisory Board, August 2015, data on file.

Request Our Newsletter

You have Successfully Subscribed!